Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicalutamide vs Total Androgen Blockade in Prostate Cancer
NCT02382094Phase 3Completed
- Sponsor
- Karolinska University Hospital
- Start
- Jun 2005
- Primary completion
- Apr 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of bicalutamide in prostate cancer (PCa), sponsored by Karolinska University Hospital. Primary endpoint: Quality of Life at 4 years. Started Jun 2005; status: completed.
02
Drugs
bicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02382094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02382094.